|
| Overcoming heterogenity in imatinib-resistant gastrointestinal stromal tumor |
|
https://doi.org/10.18632/oncotarget.27277
César Serrano, Jonathan A. Fletcher
|
| 6286-6287 |
|
| A negative feedback regulatory loop between miR-138 and TP53 is mediated by USP10 |
|
https://doi.org/10.18632/oncotarget.27275
Zhenghua Luo, Manchao Zhang, Ri Cui, Esmerina Tili, Taewan Kim, Tae Jin Lee, Yong Peng, Carlo Croce
|
| 6288-6296 |
|
| Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer |
|
https://doi.org/10.18632/oncotarget.27214
Vijay Patil, Amit Joshi, Vanita Noronha, Vivek Agarwala, Anuradha Chougule, Sadhana Kanan, Atanu Bhattacharjee, Arun Chandrasekharan, Nikhil Pande, Vijai Simha, Supriya Goud, Sucheta More, Rajiv Kumar, Abhishek Mahajan, Amit Janu, Nilendu Purandare, Kumar Prabhash
|
| 6297-6307 |
|
| Improved surgical resection of metastatic pancreatic cancer using uPAR targeted in vivo fluorescent guidance: comparison with traditional white light surgery |
|
https://doi.org/10.18632/oncotarget.27220
Karina Juhl, Anders Christensen, Niclas Rubek, Kirstine Kim Schmidt Karnov, Christian von Buchwald, Andreas Kjaer
|
| 6308-6316 |
|
| Central nervous system-specific efficacy of CDK4/6 inhibitors in randomized controlled trials for metastatic breast cancer |
|
https://doi.org/10.18632/oncotarget.27238
Long V. Nguyen, Karlee Searle, Katarzyna J. Jerzak
|
| 6317-6322 |
|
| The multikinase inhibitor RXDX-105 is effective against neuroblastoma in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.27259
Sean M. Flynn, Jacqueline Lesperance, Andrew Macias, Nikki Phanhthilath, Megan Rose Paul, Jong Wook Kim, Pablo Tamayo, Peter E. Zage
|
| 6323-6333 |
|
| Dynamic transition of the blood-brain barrier in the development of non-small cell lung cancer brain metastases |
|
https://doi.org/10.18632/oncotarget.27274
Gozde Uzunalli, Alexandra M. Dieterly, Chinyere M. Kemet, Hsin-Yi Weng, Arvin H. Soepriatna, Craig J. Goergen, Aparna B. Shinde, Michael K. Wendt, L. Tiffany Lyle
|
| 6334-6348 |
|
| Tissue ACE phenotyping in prostate cancer |
|
https://doi.org/10.18632/oncotarget.27276
Sergei M. Danilov, Alexey V. Kadrev, Olga V. Kurilova, Victoria E. Tikhomirova, Olga V. Kryukova, Vadim N. Mamedov, David M. Kamalov, Natalia V. Danilova, Dmitry A. Okhobotov, Nurshat M. Gayfullin, Valery V. Evdokimov, Boris J. Alekseev, Olga A. Kost, Larisa M. Samokhodskaya, Armais A. Kamalov
|
| 6349-6361 |
|
| Importance of activated leukocyte cell adhesion molecule (ALCAM) in prostate cancer progression and metastatic dissemination |
|
https://doi.org/10.18632/oncotarget.27279
Andrew J. Sanders, Sioned Owen, Liam D. Morgan, Fiona Ruge, Ross J. Collins, Lin Ye, Malcolm D. Mason, Wen G. Jiang
|
| 6362-6377 |
|
| Investigating the duality of Inpp4b function in the cellular transformation of mouse fibroblasts |
|
https://doi.org/10.18632/oncotarget.27293
Emily Marie Mangialardi, Keyue Chen, Brittany Salmon, Jean Vacher, Leonardo Salmena
|
| 6378-6390 |
|
| Correction: SETD2 loss sensitizes cells to PI3Kβ and AKT inhibition |
|
https://doi.org/10.18632/oncotarget.27288
Esteban A. Terzo, Aaron R. Lim, Anna Chytil, Yun Chen Chiang, Leah Farmer, Kathryn H. Gessner, Cheryl Lyn Walker, Valerie M. Jansen, W. Kimryn Rathmell
|
| 6391-6392 |
|
| Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer |
|
https://doi.org/10.18632/oncotarget.27289
Giovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro, Francesco Marampon, Roberta Sferra, Simona Pompili, Leda Assunta Biordi, Roberto Iorio, Vincenzo Flati, Christian Argueta, Yosef Landesman, Michael Kauffman, Sharon Shacham, Claudio Festuccia
|
| 6393-6395 |
|
| Correction: MiR-451 as a new tumor marker for gastric cancer |
|
https://doi.org/10.18632/oncotarget.27291
Yong Shen, Jiao-Mei Gong, Li-Li Zhou, Jia-He Sheng
|
| 6396-6396 |
|
| Correction: Impact of epidural analgesia on the systemic biomarker response after hepatic resection |
|
https://doi.org/10.18632/oncotarget.27295
Diego Vicente, Miguel Patino, Rebecca Marcus, Heather Lillemoe, Preparim Limani, Timothy Newhook, Andy Lee, Ching-Wei Tzeng, Yun Segraves-Chun, David Tweardy, Vijaya Gottumukkala, Jean-Nicolas Vauthey, Thomas Aloia, Juan P. Cata
|
| 6397-6397 |
|
| Correction: MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.27296
Zuo-Lin Xiang, Xiao-Mei Zhao, Li Zhang, Ping Yang, Jia Fan, Zhao-You Tang, Zhao-Chong Zeng
|
| 6398-6399 |
